openPR Logo
Press release

Minimal Residual Disease Pipeline | Clinical Trial, Key Companies - Amgen, Bellicum Pharmaceuticals, Synimmune, Novartis, AstraZeneca

11-03-2023 09:36 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Minimal Residual Disease Pipeline

Minimal Residual Disease Pipeline

DelveInsight's, "Minimal residual disease (MRD) - Pipeline Insights, 2023," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Minimal residual disease (MRD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Learn more @ https://www.delveinsight.com/sample-request/minimal-residual-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Minimal Residual Disease Overview
Minimal residual disease refers to the small number of cancer cells that remain in the body after cancer treatment. These cells do not cause any physical signs or symptoms. After cancer treatment, any remaining cancer cells in the body can become active and start to multiply, causing a relapse of the disease. Minimal residual disease may be present after treatment because not all of the cancer cells responded to the therapy, or because the cancer cells became resistant to the medications used. Detecting MRD may indicate that the treatment was not completely effective or that the treatment was incomplete. An MRD positive test result or negative result provides doctors an idea about the risk of relapse in cancer patients. MRD testing is mainly used in blood cancers (leukemia, lymphoma, and myeloma), but is being studied in other cancers also.

Diagnosis for the disease includes Various factors which include specific to the patient's disease. Patients may be tested after the final cycle of combination therapy, after bone marrow transplantation, during treatment, after one year of maintenance therapy, or at regular intervals after treatment is completed. The more sensitive a test is, the more effective it is at finding a small amount of cancer cells among the many healthy cells. The most widely used tests to measure MRD are flow cytometry, polymerase chain reaction (PCR), and next-generation sequencing (NGS).

Learn more about Residual Disease Pipeline @ https://www.delveinsight.com/report-store/minimal-residual-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Residual Disease Market Report Key Highlights:
The key companies working in Residual Disease include Amgen, Bellicum Pharmaceuticals, Synimmune, Novartis, AstraZeneca and many others
Pipeline therapies include FLYSYN, BPX-501, and many others


Major Players in Minimal Residual Disease
There are approx. 8+ key companies which are developing the therapies for Minimal residual disease (MRD).
Phases
DelveInsight's Report covers around 8+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued and inactive candidates

Route of Administration
Minimal residual disease (MRD) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Oral
Parenteral
intravitreal
Subretinal
Topical.
Molecule Type
Products have been categorized under various Molecule types such as
Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy
Product Type
Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Learn more about Minimal Residual Disease Pipeline @ https://www.delveinsight.com/report-store/minimal-residual-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Minimal Residual Disease Introduction
Executive Summary of Minimal Residual Disease
Disease Background and Overview
Epidemiology and patient population
Minimal Residual Disease Emerging Therapies
Minimal Residual Disease Market Outlook
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the report @

https://www.delveinsight.com/report-store/minimal-residual-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Chronic Granulomatous Disease Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Minimal Residual Disease Pipeline | Clinical Trial, Key Companies - Amgen, Bellicum Pharmaceuticals, Synimmune, Novartis, AstraZeneca here

News-ID: 3274909 • Views: …

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…

All 5 Releases


More Releases for Minimal

Medical Devices Manufacturer Focused Minimal Invasive Surgery | YUWONMEDITECH
YUWONMEDITECH, founded in 2003 and based in Korea, is a specialized medical device manufacturer with a strong focus on minimally invasive surgery (MIS) solutions. The company is dedicated to developing advanced medical technologies that reduce patient recovery times, minimize surgical impact, and improve overall patient outcomes. With nearly two decades of experience, Yuwonmeditech combines innovation and precision engineering to provide high-quality, reliable medical devices for healthcare professionals worldwide. Their expertise…
Minimal Invasive Surgery Devices Market Report 2024 - Minimal Invasive Surgery D …
"The Business Research Company recently released a comprehensive report on the Global Minimal Invasive Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The minimal invasive…
12-04-2023 | Arts & Culture
SkyWolf
New, minimal, online poetry community
In the age of social media, large corporation dominance, and AI, comes a breath of fresh air. A minimal, traditional online community, built from scratch with poetry in mind. The community is called, Kiss Poetry. The clean and calming ways of Kiss Poetry can be seen right away due to the minimal, yet modern design. On the Write page is a single box where you write. Titles are auto-detected, as well…
Minimal Frame Window System Market Trends, Challenges, and Opportunities 2023 To …
The Minimal Frame Window System market is expected to grow at a CAGR of 10.3% from 2023 to 2030. The Minimal Frame Window System market pertains to the architectural and construction industry, offering window solutions characterized by sleek, slim, and minimalist frames. These systems are designed to provide unobstructed views and maximize natural light in buildings. Minimal frame window systems are highly sought after in modern architecture and interior design for…
Minimal Window System Market Size Estimation: 2022, Development Trends , Growth …
The "Minimal Window System Market" Report 2022 provides a comprehensive analysis of the current market size, observable trends, key regions, growth rate, and projections. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. The report provides a detailed assessment of the key market dynamics and a qualitative analysis of the structure of the Minimal Window…
EvolIft® - Lift Off for minimal friction
In order to achieve the European Union's climate protection targets, CO2 emissions at fleet level must be reduced to < 60g CO2/km by 2030. The contribution of the sealing industry is, to reduce power losses to a technically possible minimum. KACO has further developed a principle based on turbine technology to enable its application in the automotive sector as well as in other industrial areas. The dynamic seal with the…